Fannin UK Completes Integration of ISKUS Health UK Business

The integration broadens Fannin UK’s portfolio of medical devices and solutions, providing healthcare providers across the UK with improved access to a wider range of innovative and high-quality products.

Fannin UK has officially completed the integration of ISKUS Health UK into its business, following regulatory approval from the Competition and Consumer Protection Commission, marking a significant step in expanding its presence in the UK medical devices market.

The integration broadens Fannin UK’s portfolio of medical devices and solutions, providing healthcare providers across the UK with improved access to a wider range of innovative and high-quality products.

Established in 2012 as part of the ISKUS Health Group, ISKUS Health UK has built a reputation as a trusted supplier of medical and surgical devices, consumables, and sterile single-use products.

By combining Fannin UK’s scale and operational expertise with ISKUS Health UK’s clinical focus, the integration aims to enhance patient safety, efficiency and care outcomes, while offering a market-leading product portfolio.

As part of the integration, Stuart Murray, co-founder and former Commercial Director within the ISKUS Health Group, has assumed the role of Commercial Director of Fannin UK and its International Surgical Division.

With more than 25 years of experience across UK and international healthcare markets, Murray joins Fannin alongside the wider ISKUS Health UK sales team, which has been fully integrated to strengthen nationwide sales capacity while maintaining customer relationships.

“Joining Fannin UK is an exciting step for ISKUS Health UK,” said Stuart Murray, Commercial Director of the Fannin Surgical Division.

“Our team has been fully integrated into Fannin UK’s sales divisions and territories, enabling customers to benefit from Fannin’s broader resources, logistics capabilities and UK-wide support, while maintaining access to the superb range of ISKUS Health products. This integration ensures continuity of experience and relationships with healthcare providers across the UK.”

ISKUS Health UK adds several product ranges to the Fannin portfolio, including the Kurin Jet blood culture collection system, Swash patient hygiene products, DryMax fluid-control floor mats, Tecnodrape Iodine surgical incise drapes, tracheostomy and wound drainage products from Primed, non-sterile clinical apparel, surgical draping solutions and procedure kits.

Commenting on the development, Chris Soanes, Managing Director at Fannin UK, "This integration represents a significant milestone for both organisations and most importantly, for the healthcare professionals and patients we serve."

"By combining ISKUS Health UK's surgical expertise with Fannin UK's extensive portfolio, we are enhancing our ability to provide comprehensive, reliable solutions to the UK healthcare sector."

Fannin UK said the ISKUS Health UK team will be fully integrated into its operations, ensuring service continuity and ongoing support for existing customers. ISKUS Health Ltd in Ireland will continue to operate as a stand-alone business serving the Irish market, including Northern Ireland.

Stay tuned for more such updates on Digital Health News